Dr. Chipkin has a long-standing interest in understanding ways to reduce the cardiovascular complications of diabetes mellitus. He has studied interactions between medications and lifestyle factors such as diet and physical activity. Funded projects have included both clinical trials and public health programs. He has been funded by local donors, private foundations, state agencies and the federal government.
Cardiovascular disease is the major cause of death for people with diabetes. The rising rates of obesity and pre-diabetes have further raised the risk for heart disease and stroke among people with “metabolic syndrome” which includes the clustering of high blood pressure, high cholesterol, excess body fat and abnormal blood sugar levels. Dr. Chipkin has studied these problems utilizing a range of approaches from clinical trials to public health programs. He is happy to discuss clinical applicability of any project.
Prior to his appointment at UMass, Dr. Chipkin was a faculty member of Tufts University Medical School for seven years and Boston University School of Medicine for 10 years.
- BS Emory Unviersity, Atlanta GA
- MD SUNY Downstate, Brooklyn, NY
- Fellowship (Endocrinology, Diabetes and Metabolism)- UMass Worcester